Joseph I. Sirven

Joseph I. Sirven

Auto-generated profile, based on publicly available information

Joseph I. Sirven

Department of Neurology, Mayo Clinic, Scottsdale, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
JSJoseph I. Sirven
Joseph I. Sirven
DWDean M. Wingerchuk
Dean M. Wingerchuk
JDJoseph F. Drazkowski
Joseph F. Drazkowski
MLMark K. Lyons
Mark K. Lyons
RZRichard S. Zimmerman
Richard S. Zimmerman

1 September 2015 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Open access
PDF file
JSJoseph I. Sirven
Joseph I. Sirven
Epilepsy, a disorder of unprovoked seizures is a multifaceted disease affecting individuals of all ages with a particular predilection for the very young and old. In addition to seizures, many patients often report cognitive and psychiatric problems associated with both the seizures themselves and its therapy. Epilepsy has numerous etiologies both idiopathic and acquired with a wide range of therapeutic responses. Despite numerous treatments available to control repetitive seizures including medications, diets, immunotherapy, surgery, and neuromodulatory devices, a large percentage of patients continue to suffer the consequences of uncontrolled seizures, which include psychosocial stigma and death.

1 December 1999 in Epilepsia
Verified
Journal Article
Closed access
PDF file
JSJoseph Sirven
Joseph Sirven
BWBarbara Whedon
Barbara Whedon
DCDeborah Caplan
Deborah Caplan
JLJoyce Liporace
Joyce Liporace
DGDavid Glosser
David Glosser
MSMichael R. Sperling
Michael R. Sperling

23 July 2001
Verified
Reference Entry
Closed access
PDF file
JSJoseph Sirven
Joseph Sirven
MSMichael R Sperling
Michael R Sperling
DWDean M Wingerchuk
Dean M Wingerchuk

14 March 2000 in Neurology
Verified
Journal Article
Closed access
PDF file
JSJ.I. Sirven
J.I. Sirven
MSM. Sperling
M. Sperling
DND. Naritoku
D. Naritoku
SSS. Schachter
S. Schachter
DLD. Labar
D. Labar
JSJ.D. Sanchez
J.D. Sanchez
Article abstract The authors assessed the efficacy, safety, and tolerability of vagus nerve stimulation (VNS) for refractory epilepsy in 45 adults 50 years of age and older. They determined seizure frequency, adverse effects, and quality of life. At 3 months, 12 patients had a >50% decrease in seizure frequency; at 1 year, 21 of 31 studied individuals had a >50% seizure decrease. Side effects were mild and transient. Quality of life scores improved significantly with time.

12 February 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
ISIsabella Strozzi
Isabella Strozzi
SNSarah J Nolan
Sarah J Nolan
MSMichael R Sperling
Michael R Sperling
DWDean M Wingerchuk
Dean M Wingerchuk
JSJoseph Sirven
Joseph Sirven